The London Company Small Cap portfolio increased 2.7% (2.4% net) during the quarter vs. an 8.5% increase in the Russell 2000 ...

The London Company Mid Cap portfolio increased 5.7% during the second quarter (5.5% net) vs. an 8.5% increase in the Russell ...

The process of applying for a business loan is easier than ever in 2025, and most of the steps can be completed online.

Announced positive topline results from registrational STAAR study in Fabry disease, including positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across all dosed ...

Soquelitinib data from cohort 3 of atopic dermatitis Phase 1 clinical trial demonstrates earlier and deeper responses compared to cohorts 1-2 along with clinically meaningful reduction in itch as ...

For the past three years I've been paying £500 per month into my company's Sharesave scheme, which finishes in August.

Bayer disclosed that its Q2 earnings were inflated by transfer fees at its German football club Bayer Leverkusen.

The basketball league warns that any spectators throwing objects onto the court will face a minimum one-year ban and ...

Announce top-line results from PEAK in the second half of 2025. PEAK is a global, blinded, randomized Phase 3 clinical trial studying the combination of bezuclastinib and sunitinib versus sunitinib ...

Net Loss: Net loss for the three months ended June 30, 2025, totaled $17.6 million, with non-cash stock-based compensation expense of $4.2 million, compared to $7.9 million for the same period in 2024 ...

Research and Development (R&D) Expenses: R&D expense was $22.7 million for the second quarter of 2025, as compared to $15.7 million for the prior year period. The increase in R&D expense was primarily ...

LOQTORZI net revenue was $10.0 million, a 36% increase over Q1 2025 – – Data readouts for CHS-114 and casdozokitug on track for 1H 2026 ...